Dopamine News and Research

Latest Dopamine News and Research

Innovative tissue expansion technique transforms conventional microscopy capabilities

A classical way to image nanoscale structures in cells is with high-powered, expensive super-resolution microscopes. As an alternative, MIT researchers have developed a way to expand tissue before imaging it - a technique that allows them to achieve nanoscale resolution with a conventional light microscope.

12 Oct 2024

Excess sugar consumption triggers inflammation and dysbiosis, worsening periodontal disease

Research explores how excessive sugar consumption can drive systemic inflammation, disrupt the gut and oral microbiomes, and contribute to periodontal inflammation, with implications for global health.

10 Oct 2024

Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease

Parkinson's disease is most known for its movement-related symptoms: tremors and rigidity, slowness and falls, caused by the loss of the brain's dopamine-producing neurons.

4 Oct 2024

Study identifies ophthalmic acid as an alternative to dopamine in motor control

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.

4 Oct 2024

Fruit fly brain connectome offers critical clues for understanding brain function and behavior

A scientific team supported by the National Institutes of Health (NIH) unveiled the first complete map of the neural connections of the common fruit fly brain. The map provides a wiring diagram, known as a connectome, and is the largest and most complete connectome of an adult animal ever created.

3 Oct 2024

New study challenges dopamine's role in placebo effects and pain relief

New findings argue against a direct causal role for dopamine during the experience of a treatment effect in the establishment of positive treatment expectations and placebo analgesia in healthy volunteers, according to a study published September 24th in the open-access journal PLOS Biology by Ulrike Bingel from University Hospital Essen, Germany, and colleagues.

24 Sep 2024

Study uncovers decision-making impairments linked to Parkinson's drug

Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of people worldwide.

24 Sep 2024

Groundbreaking project seeks to illuminate the complexities of Parkinson's

Launching today, Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The project brings together Parkinson’s UK, Imperial College London, GSK, Novartis, Roche and UCB for the first time, and has been made possible by a founding gift of £4 million from the Gatsby charitable foundation.

24 Sep 2024

How plant-based, Mediterranean, and Western diets affect gut microbiota and disease

Researchers examine how different dietary components affect the gut microbiome and development of non-communicable diseases.

20 Sep 2024

Impact of oxidative stress, gut, and diet on attention deficit hyperactivity disorder pathophysiology

Oxidative stress and gut microbiome interactions are key in ADHD pathogenesis, with diet playing a crucial role in managing symptoms and improving outcomes.

18 Sep 2024

Iron deficiency linked to restless sleep in ADHD and autism

Researchers examine the relationship iron deficiency and sleep-related disorders.

17 Sep 2024

New microscopy technique detects early Parkinson's disease indicators

Researchers at Tel Aviv University cooperated with three major Israeli medical centers to develop a new method for detecting protein aggregation in cells – a hallmark of Parkinson's disease.

16 Sep 2024

High-dose amphetamine use linked to increased risk of psychosis or mania

Prescribing rates for stimulants that treat attention-deficit/hyperactivity disorder (ADHD) have increased significantly over the past decade, with some of the largest increases reported during the COVID-19 pandemic.

12 Sep 2024

TAAR1 gene: A new key to mental health

In the complex landscape of mental health research, a new peer-reviewed Viewpoint review sheds light on an underexplored genetic player: the trace amine-associated receptor 1 (TAAR1). Published in Genomic Psychiatry (ISSN: 2997-2388, Genomic Press, New York), this thought-provoking analysis suggests that mutations in the TAAR1 gene may be a crucial piece of the puzzle in understanding and treating neuropsychiatric disorders.

11 Sep 2024

Tips for parents to safeguard children from online gaming risks

As online gaming becomes an increasingly popular pastime among children, parents continue to grow concerned about the potential risks and dangers their children may be facing.

30 Aug 2024

GPePV neurons identified as key players in controlling cocaine addiction behaviors

Researchers examine how GPePV cells regulate cocaine-induced behaviors through interactions with ventral tegmental area dopamine cells.

25 Aug 2024

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

Researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson's disease.

22 Aug 2024

The critical role of PGK1 in Parkinson's disease

An enzyme called PGK1 has an unexpectedly critical role in the production of chemical energy in brain cells, according to a preclinical study led by researchers at Weill Cornell Medicine. The investigators found that boosting its activity may help the brain resist the energy deficits that can lead to Parkinson's disease.

21 Aug 2024

UCSF studies point the way toward continuous care for people with Parkinson's disease

Two new studies from UC San Francisco are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems during the day and insomnia at night.

19 Aug 2024

New findings reveal how serotonin shapes behavior in negative situations

Researchers increased synaptic serotonin through a selective serotonin-releasing agent, fenfluramine, to investigate its impact on human behavior.

14 Aug 2024

Dopamine News and Research

Latest Dopamine News and Research

Innovative tissue expansion technique transforms conventional microscopy capabilities

Excess sugar consumption triggers inflammation and dysbiosis, worsening periodontal disease

Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease

Study identifies ophthalmic acid as an alternative to dopamine in motor control

Fruit fly brain connectome offers critical clues for understanding brain function and behavior

New study challenges dopamine's role in placebo effects and pain relief

Study uncovers decision-making impairments linked to Parkinson's drug

Groundbreaking project seeks to illuminate the complexities of Parkinson's

How plant-based, Mediterranean, and Western diets affect gut microbiota and disease

Impact of oxidative stress, gut, and diet on attention deficit hyperactivity disorder pathophysiology

Iron deficiency linked to restless sleep in ADHD and autism

New microscopy technique detects early Parkinson's disease indicators

High-dose amphetamine use linked to increased risk of psychosis or mania

TAAR1 gene: A new key to mental health

Tips for parents to safeguard children from online gaming risks

GPePV neurons identified as key players in controlling cocaine addiction behaviors

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

The critical role of PGK1 in Parkinson's disease

UCSF studies point the way toward continuous care for people with Parkinson's disease

New findings reveal how serotonin shapes behavior in negative situations

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Dopamine News and Research

Latest Dopamine News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in